150 related articles for article (PubMed ID: 21188533)
1. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.
Butkiewicz D; Rusin M; Sikora B; Lach A; Chorąży M
Mol Biol Rep; 2011 Nov; 38(8):5231-41. PubMed ID: 21188533
[TBL] [Abstract][Full Text] [Related]
2. Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.
Butkiewicz D; Drosik A; Suwiński R; Krześniak M; Rusin M; Kosarewicz A; Rachtan J; Matuszczyk I; Gawkowska-Suwińska M
Int J Cancer; 2012 Oct; 131(7):E1100-8. PubMed ID: 22511383
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
4. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
5. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
6. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.
Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
[TBL] [Abstract][Full Text] [Related]
7. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in DNA repair genes and risk of lung cancer.
Butkiewicz D; Rusin M; Enewold L; Shields PG; Chorazy M; Harris CC
Carcinogenesis; 2001 Apr; 22(4):593-7. PubMed ID: 11285194
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
13. Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
Jin ZY; Zhao XT; Zhang LN; Wang Y; Yue WT; Xu SF
Genet Mol Res; 2014 Mar; 13(3):7617-25. PubMed ID: 24737519
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.
El-Zein R; Monroy CM; Etzel CJ; Cortes AC; Xing Y; Collier AL; Strom SS
Cancer; 2009 Apr; 115(8):1651-9. PubMed ID: 19280628
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
16. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
[TBL] [Abstract][Full Text] [Related]
17. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
19. APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese.
Osawa K; Miyaishi A; Uchino K; Osawa Y; Inoue N; Nakarai C; Tsutou A; Kido Y; Yoshimura M; Tsubota N; Takahashi J
Asian Pac J Cancer Prev; 2010; 11(5):1181-6. PubMed ID: 21198260
[TBL] [Abstract][Full Text] [Related]
20. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
